Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas

Oncology Reports

Volumn 13, Issue 5, 2005, Pages 949-956

  Kardas, Iwona ^a   Mrózek, Krzysztof ^b   Babinska, Malgorzata ^a   Krajka, Kazimierz ^a   Hadaczek, Piotr ^c   Lubinski, Jan ^c   Roszkiewicz, Andrzej ^a   Kuziemska, Ewa ^a   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

Chromosome 3; Cytogenetic analysis; Loss of heterozygosity; Renal cell carcinoma; Tumor aggressiveness

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; FEMALE; GENETICS; HUMAN; KARYOTYPING; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; FEMALE; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 25144444457     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.5.949     Document Type: Article

References (43)

1. Mitelman F, Johansson B and Mertens F (eds): Mitelman Database of Chromosome Aberrations in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman), 2004.
2. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G and Sumegi J: Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85: 1571-1575, 1988. (Pubitemid 18070801)
3. Kovacs G and Frisch S: Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 49: 651-659, 1989. (Pubitemid 19050331)
4. Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair W and Jhanwar SC: Histopathological, cytogenetic and molecular characterization of renal cortical tumors. Cancer Res 51: 1544-1552, 1991.
5. Limon J, Mrózek K, Heim S, et al: On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma. Cancer Genet Cytogenet 49: 259-263, 1990. (Pubitemid 20372142)
6. Verdorfer I, Hobisch A, Hittmair A, Duba H-CH, Bartsch G, Utermann G and Erdel M: Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification. Cancer Genet Cytogenet 111: 61-70, 1999. (Pubitemid 29214337)
7. Morita R, Ishikawa J, Tsutsumi M, et al: Allelotype of renal cell carcinoma. Cancer Res 51: 820-823, 1991.
8. Van der Hout AH, van den Berg E, van der Vlies P, et al: Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer 53: 353-357, 1993.
9. Foster K, Crossey PA, Cairns P, et al: Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69: 230-234, 1994. (Pubitemid 24046542)
10. Hadaczek P, Podolski J, Toloczko A, et al: Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations. Virchows Arch 429: 37-42, 1996. (Pubitemid 26341146)
11. Sükösd F, Kuroda N, Beothe T, Kaur AP and Kovacs G: Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63: 455-457, 2003. (Pubitemid 36152507)
12. Gronwald J, Storkel S, Holtgreve-Grez H, et al: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3q copy number changes in metastatic events. Cancer Res 57: 481-487, 1997. (Pubitemid 27081668)
13. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62: 89-124, 1993.
14. Kovacs G: Molecular differential pathology of renal cell tumours. Histopathology 22: 1-8. 1993.
15. Velickovic M, Delahunt B, Storkel S and Grebe SKG: VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res 61: 4815-4819, 2001. (Pubitemid 32691896)
16. Beroud C, Fournet JC, Jeanpierre C, et al: Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 17: 215-224, 1996. (Pubitemid 26423999)
17. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE and Tartof KD: Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 55: 6189-6195, 1995.
18. Elfving P, Mandahl N, Lundgren R, et al: Prognostic implications of cytogenetic findings in kidney cancer. Br J Urol 80: 698-706, 1997. (Pubitemid 28316331)
19. Herbers J, Schullerus D, Müller H, et al: Significance of chromosome arm 14q loss in non-papillary renal cell carcinomas. Genes Chromosomes Cancer 19: 29-35, 1997. (Pubitemid 27193717)
20. Gunawan B, Huber W, Holtrup M, et al: Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 61: 7731-7738, 2001. (Pubitemid 33049357)
21. Limon J, Dal Cin P and Sandberg AA: Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23: 305-313, 1986. (Pubitemid 17211786)
22. Mitelman F (ed): ISCN: An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, 1995.
23. Lubinski J, Chosia M, Kotanska K and Huebner K: Genotypic analysis of DNA isolated from fine needle aspiration biopsies. Anal Quant Cytol Histol 10: 383-390, 1988. (Pubitemid 19029733)
24. Lubinski J, Hadaczek P, Podolski J, et al: Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res 54: 3710-3713, 1994. (Pubitemid 24241184)
25. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR and Quirke P: Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67: 1262-1267, 1993. (Pubitemid 23172863)
26. Meloni AM, Bridge J and Sandberg AA: Reviews on chromosome studies in urological tumors. I. Renal tumors. J Urol 148: 253-265, 1992.
27. Erlandsson R: Molecular genetics of renal cell carcinoma. Cancer Genet Cytogenet 104: 1-18, 1998.
28. Granata P, Portentoso P, Minelli E, et al: Clonal chromosome changes in renal carcinoma do not correlate with clinical stages and histopatologic grades. Cancer Genet Cytogenet 64: 30-34, 1992. (Pubitemid 23013723)
29. Teyssier JR and Ferre D: Chromosomal changes in renal cell carcinoma. No evidence for correlation with clinical stage. Cancer Genet Cytogenet 45: 197-205, 1990. (Pubitemid 20129142)
30. Zhao WP, Gnarra JR, Liu S, Knutsen T, Linehan WM and Whang-Peng J: Renal cell carcinoma: cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 82: 128-139, 1995.
31. Weaver DJ, Michalski K and Miles J: Cytogenetic analysis in renal cell carcinoma: correlation with tumor aggressiveness. Cancer Res 48: 2887-2889, 1988.
32. Podolski J, Huzarski T, Byrski T, et al: Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas. Pol J Pathol 46: 163-166, 1995.
33. nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15: 2233-2239, 1997.
34. Pérot C, Boccon-Gibod L, Bouvier R, et al: Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. Cancer Genet Cytogenet 143: 93-99, 2003. (Pubitemid 36629315)
35. Kovacs G, Szucs S, De Riese W and Baumgärtel H: Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 40: 171-178, 1987. (Pubitemid 17126125)
36. Dijkhuizen T, van den Berg E. Wilbrink M, et al: Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations. Genes Chromosomes Cancer 14: 43-50, 1995.
37. Meloni AM, Dobbs RM, Pontes JE and Sandberg AA: Translocation (X;1) in papillary renal cell carcinoma: a new cytogenetic subtype. Cancer Genet Cytogenet 65: 1-6, 1993. (Pubitemid 23070699)
38. Kardas I, Denis A, Babinska M, et al: Translocation (X;1) (p11.2;q21) in papillary renal cell carcinoma in a 14-year-old girl. Cancer Genet Cytogenet 101: 159-161, 1998. (Pubitemid 28141181)
39. Argani P, Antonescu CR, Couturier J, et al: PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1) (p11.2;q21). Am J Surg Pathol 26: 1553-1566, 2002. (Pubitemid 35387219)
40. Amo-Takyi BK, Handt S, Gunawan B, Hollweg HG and Fuzesi L: A cytogenetic approach to the differential diagnosis of metastatic clear cell renal carcinoma. Histopathology 32: 436- 443, 1998.
41. De Jong B, Oosterhuis JW, Idenburg VJ, Castedo SM, Dam A and Mensink HJ: Cytogenetics of 12 cases of renal adenocarcinoma. Cancer Genet Cytogenet 30: 53-61, 1988. (Pubitemid 18033788)
42. Walter TA, Berger CS and Sandberg AA: The cytogenetics of renal tumors. Where do we stand, where do we go? Cancer Genet Cytogenet 43: 15-34, 1989. (Pubitemid 19281686)
43. Kovacs G, Fuzesi L, Emanual A and Kung HF: Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3: 249-255, 1991.